Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans,; which met in Lyon, June 2013.
The aseptic and safe handling standards and recommendations in this manual meet best practice standards set forth by WorkSafe BC, NIOSH, ASHP, ISOPP, USP797, CSHP, and CAPhO
This book contains general information about WHMIS 2015. It summarizes key changes from the original WHMIS, describes the four main elements of WHMIS 2015 (classification, labels, safety data sheets, and education and training), and outlines the responsibilities of suppliers, employers, and workers.
Table of Contents; 1: INTRODUCTION TO DOSING MEDICATIONS IN OBESE PATIENTS; 2: ANTIMICROBIAL DOSING IN OBESITY; 3: ANTICOAGULANTS AND ANTIPLATELETS; 4: CRITICAL CARE; 5: ANTIEPILEPTICS; 6: DOSING ANTINEOPLASTIC MEDICATIONS IN OBESE PATIENTS; 7: PEDIATRICS; 8: IMMUNOSUPPRESSION DOSING IN OBESE SOLID…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 14-21 October 2008.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents may be viewed at URL.
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
"Incidence of cancer is increasing all over the world and personalized therapies have become the trend in cancer therapy. Multidisciplinary approaches provide successful results for personalized therapies. As a part of a multidisciplinary healthcare team, oncology pharmacists (OPs) contribute to th…